Insider · CIK 0001190105
Michael L Moehn
cfoofficer
Files at AEE (AMEREN CORP). First filing Nov 22, 2024, latest Feb 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AEE: AMEREN CORP
AEEOct 9, 2026 · close 102.19
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 37Weak | sell 810b5-1 | AEE AMEREN CORP | $634k | 6,500 | -3% | +17% from low · -1% from high | |
| 21Weak | sell10b5-1 | AEE AMEREN CORP | $599k | 6,500 | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | AEE AMEREN CORP | FTax withholding Common Stock, $.01 Par Value | -13,344 | $101.56 | $1.4M | 216,675 | Mar 4, 2025 |
| Feb 20, 2025 | AEE AMEREN CORP | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -6,500 | $97.54 | $634k | 230,016 | Feb 24, 2025 |
| Feb 6, 2025 | AEE AMEREN CORP | AGrant or award Common Stock, $.01 Par Value | +9,307 | $0.00 | $0 | 214,477 | Feb 10, 2025 |
| Feb 6, 2025 | AEE AMEREN CORP | AGrant or award Common Stock, $.01 Par Value | +21,437 | $0.00 | $0 | 236,516 | Feb 10, 2025 |
| Nov 20, 2024 | AEE AMEREN CORP | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -6,500 | $92.15 | $599k | 205,171 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.